Fatty liver allografts are associated with primary graft non-function and high mortality after transplantation.

about

Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?

P2860

Q52584505-F42E2258-0D52-4897-9718-5D701D4ECA91

P2860

Fatty liver allografts are associated with primary graft non-function and high mortality after transplantation.

Item

http://www.wikidata.org/entity/Q48121039

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Fatty liver allografts are ass ...... rtality after transplantation.

@en

Fatty liver allografts are ass ...... rtality after transplantation.

@nl

type

Item

label

Fatty liver allografts are ass ...... rtality after transplantation.

@en

Fatty liver allografts are ass ...... rtality after transplantation.

@nl

prefLabel

Fatty liver allografts are ass ...... rtality after transplantation.

@en

Fatty liver allografts are ass ...... rtality after transplantation.

@nl

P1476

Fatty liver allografts are ass ...... rtality after transplantation.

@en

P2093

Sandra Milic

http://www.w3.org/2001/XMLSchema#string

Tajana Filipec-Kanizaj

http://www.w3.org/2001/XMLSchema#string

P2860

Nonalcoholic fatty liver disease - A multisystem disease?

Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

NAFLD and liver transplantation: Current burden and expected challenges.

Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.

Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death.

Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.

Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors.

Usefulness of liver test and controlled attenuation parameter in detection of nonalcoholic fatty liver disease in patients with chronic renal failure and coronary heart disease.

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort.

P304

1113-1115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/LIV.13453

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ivana Mikolasevic

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28710818

http://www.w3.org/2001/XMLSchema#string

Fatty liver allografts are associated with primary graft non-function and high mortality after transplantation.

about

P2860

P2860

Fatty liver allografts are associated with primary graft non-function and high mortality after transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698